$ISPR
Ispire Technology Inc.

2024 Q4 Form 10-Q Financial Statement

#000121390024096805 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024 Q2
Revenue $39.34M $37.34M
YoY Change -8.23% 14.45%
Cost Of Revenue $31.66M $26.78M
YoY Change -11.99% 2.99%
Gross Profit $7.674M $10.56M
YoY Change 11.41% 59.44%
Gross Profit Margin 19.51% 28.29%
Selling, General & Admin $12.94M $13.92M
YoY Change 65.87% 129.84%
% of Gross Profit 168.58% 131.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $188.5K $1.579M
YoY Change 547.45% 6024.9%
% of Gross Profit 2.46% 14.95%
Operating Expenses $12.94M $13.92M
YoY Change 65.87% 129.84%
Operating Profit -$5.263M -$3.352M
YoY Change 477.53% -687.52%
Interest Expense $117.7K $960.00
YoY Change 55.01% -100.25%
% of Operating Profit
Other Income/Expense, Net $124.6K $108.6K
YoY Change -388.44% -332.41%
Pretax Income -$5.138M -$3.243M
YoY Change 484.84% -2511.36%
Income Tax $456.8K $178.3K
% Of Pretax Income
Net Earnings -$5.595M -$3.421M
YoY Change 307.02% 8278.96%
Net Earnings / Revenue -14.22% -9.16%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.10 -$0.06
COMMON SHARES
Basic Shares Outstanding 56.65M shares 56.64M shares 56.40M shares
Diluted Shares Outstanding 56.60M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.73M $35.07M
YoY Change 8.18% -29.05%
Cash & Equivalents $37.73M $35.07M
Short-Term Investments $0.00
Other Short-Term Assets $1.431M $1.400M
YoY Change -16.79% -58.56%
Inventory $6.992M $6.365M
Prepaid Expenses
Receivables $62.36M $59.73M
Other Receivables $0.00 $488.1K
Total Short-Term Assets $108.5M $102.6M
YoY Change 32.96% 20.94%
LONG-TERM ASSETS
Property, Plant & Equipment $2.663M $2.582M
YoY Change 67.25% 137.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.17M $10.25M
YoY Change
Other Assets $291.7K $284.1K
YoY Change -95.71% -95.17%
Total Long-Term Assets $20.44M $20.07M
YoY Change 200.86% 241.19%
TOTAL ASSETS
Total Short-Term Assets $108.5M $102.6M
Total Long-Term Assets $20.44M $20.07M
Total Assets $129.0M $122.6M
YoY Change 45.86% 35.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.342M $3.780M
YoY Change -91.43% 196.59%
Accrued Expenses $1.179M $1.012M
YoY Change 6712.11% 2723.86%
Deferred Revenue $2.246M $2.218M
YoY Change 74.06% 124.38%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $96.37M $85.99M
YoY Change 78.44% 53.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.870M $2.194M
YoY Change -44.8% -34.63%
Total Long-Term Liabilities $1.870M $2.194M
YoY Change -44.8% -34.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $96.37M $85.99M
Total Long-Term Liabilities $1.870M $2.194M
Total Liabilities $98.24M $88.18M
YoY Change 71.16% 48.66%
SHAREHOLDERS EQUITY
Retained Earnings -$14.42M -$8.825M
YoY Change -422.37% -250.91%
Common Stock $5.664K $5.647K
YoY Change 4.37% 4.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.71M $34.46M
YoY Change
Total Liabilities & Shareholders Equity $129.0M $122.6M
YoY Change 45.86% 35.23%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$5.595M -$3.421M
YoY Change 307.02% 8278.96%
Depreciation, Depletion And Amortization $188.5K $1.579M
YoY Change 547.45% 6024.9%
Cash From Operating Activities $3.610M -$1.424M
YoY Change -128.03% -85.52%
INVESTING ACTIVITIES
Capital Expenditures $268.8K $958.3K
YoY Change -49.58% 82.28%
Acquisitions
YoY Change
Other Investing Activities -$2.000M
YoY Change -524.89%
Cash From Investing Activities -$925.2K -$2.958M
YoY Change 17.3% 5278.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $3.610M -1.424M
Cash From Investing Activities -$925.2K -2.958M
Cash From Financing Activities 0.000
Net Change In Cash $2.685M -4.382M
YoY Change -118.37% -126.94%
FREE CASH FLOW
Cash From Operating Activities $3.610M -$1.424M
Capital Expenditures $268.8K $958.3K
Free Cash Flow $3.341M -$2.382M
YoY Change -124.91% -77.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
001-41680
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
Ispire Technology Inc.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
93-1869878
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90502
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
19700 Magellan Drive
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q3 dei City Area Code
CityAreaCode
(310)
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
742-9975
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2024Q3 dei Trading Symbol
TradingSymbol
ISPR
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56646518 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37731954 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35071294 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
24280 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62359322 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59734765 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
6992025 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
6365394 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1406822 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1400152 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
108514403 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
102571605 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2662714 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2582457 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2015805 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1375666 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3295952 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3579140 usd
CY2024Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
2000000 usd
CY2024Q2 us-gaap Other Long Term Investments
OtherLongTermInvestments
2000000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
10172075 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
10248048 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
291699 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
284050 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
20438245 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
20069361 usd
CY2024Q3 us-gaap Assets
Assets
128952648 usd
CY2024Q2 us-gaap Assets
Assets
122640966 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4341642 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3779723 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2245505 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2218166 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12139232 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11738339 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
399995 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1240726 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1207832 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
96368722 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
85990532 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1869951 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2194094 usd
CY2024Q3 us-gaap Liabilities
Liabilities
98238673 usd
CY2024Q2 us-gaap Liabilities
Liabilities
88184626 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
140000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56641041 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56641041 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56470636 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56470636 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5664 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5647 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45224962 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43217391 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14420057 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8825041 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96594 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
58343 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
30713975 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
34456340 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128952648 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
122640966 usd
CY2024Q3 us-gaap Revenues
Revenues
39338313 usd
CY2023Q3 us-gaap Revenues
Revenues
42864647 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
31663935 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
36019799 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
7674378 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
6844848 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2992247 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1025219 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9945000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6697874 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12937247 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7723093 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5262869 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-878245 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
86 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
72246 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
117585 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3661 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6935 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-43204 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
124606 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
32703 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5138263 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-845542 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
456753 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
496045 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5595016 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1341587 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-154937 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
44463 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5749953 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1297124 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56601320 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56601320 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54246212 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54246212 shares
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
34456340 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5595016 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1119111 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
888477 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
154937 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
30713975 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
31469910 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1341587 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
325616 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
641943 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent
-44463 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
31140345 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5595016 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1341587 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
204807 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29161 usd
CY2024Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
3102081 usd
CY2023Q3 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
225487 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
283188 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
287481 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2007588 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
967560 usd
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
73692 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-75973 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5726638 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14710476 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
700323 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1863080 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14319 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1603180 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
9517069 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2449276 usd
CY2024Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-87402 usd
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
281529 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
360697 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-124950 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
399995 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
496138 usd
CY2024Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-291249 usd
CY2023Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-249753 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3610143 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13122426 usd
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
268781 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
533122 usd
CY2024Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
656422 usd
CY2023Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
255650 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-925203 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-788772 usd
CY2023Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
703323 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-703323 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2684940 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-14614521 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35071294 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40300573 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37756234 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25686052 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37731954 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25686052 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
24280 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37756234 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25686052 usd
CY2023Q3 ispr Leased Assets Obtained In Exchange For Operating Lease Liabilities
LeasedAssetsObtainedInExchangeForOperatingLeaseLiabilities
537307 usd
CY2024Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
44738 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
11464 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of significant estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates include allowance for credit losses, revenue recognition, fair value of equity instruments, inventory reserve, incremental borrowing rate, and determination of the valuation allowances for deferred taxes. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
279286 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
205594 usd
CY2024Q3 ispr Finite Lived Patent Gross
FiniteLivedPatentGross
656422 usd
CY2023Q3 ispr Finite Lived Patent Gross
FiniteLivedPatentGross
255650 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16283 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Percentage Of Interest Bearing Domestic Deposits To Deposits
PercentageOfInterestBearingDomesticDepositsToDeposits
0.30 pure
CY2024Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.70 pure
CY2024Q3 us-gaap Revenues
Revenues
39338313 usd
CY2023Q3 us-gaap Revenues
Revenues
42864647 usd
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Customer and Supplier Concentration</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended September 30, 2024 and 2023, the Company’s major customers, who accounted for more than 10% of the Company’s consolidated revenue, were as follows:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Major Customers</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">21</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">35</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-38; font-size: 10pt">*</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-39; font-size: 10pt">*</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-size: 10pt">*</span></td> <td><span style="font-size: 10pt">Represented less than 10% of consolidated revenue.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended September 30, 2024 and 2023, the Company’s suppliers, who accounted for more than 10% of the Company’s total purchases, were as follows:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Major Suppliers</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%"><span style="font-size: 10pt">D<sup>(1)</sup></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">96</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">69</td><td style="width: 1%; text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-size: 10pt"><sup>(1)</sup></span></td> <td style="text-align: justify"><span style="font-size: 10pt">Major supplier D is Shenzhen Yi Jia, a Chinese company that is 95% owned by the Company’s co-chief executive officer and principal stockholder. See Note 10.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Credit Risk</span> <b> </b></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and accounts receivable. The Company maintains its cash in financial institutions. Accounts at United States financial institutions are insured by the Federal Deposit Insurance Corporation(“FDIC”) up to $250,000. Accounts at Malaysian financial institutions are insured by the Perbadanan Insurans Deposit Malaysia (“PIDM”) up to <span style="-sec-ix-hidden: hidden-fact-40">RM250,000</span>. The Hong Kong Deposit Protection Board pays compensation up to a limit of Hong Kong Dollar (“HKD”) 500,000. The Company may carry cash balances at financial institutions in excess of the insured limits. The amount in excess of the deposit insurance as of September 30, 2024 and June 30, 2024 was $37,355,502 and $34,698,647. The Company has not experienced losses on these accounts and management believes, based upon the quality of the financial institutions, that the credit risk with regard to these deposits is not significant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of September 30, 2024 and June 30, 2024, the Company’s customers, whose accounts receivable balances accounted for more than 10% of the Company’s total accounts receivable, were as follows:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">As of <br/> September 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">As of <br/> June 30,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Customers</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify">E</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">15</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">16</td><td style="width: 1%; text-align: left">%</td></tr> </table>
CY2024Q3 ispr Fdic Insurance Limit
FDICInsuranceLimit
500000 hkd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
37355502 usd
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
34698647 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37731954 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35071294 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37731954 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35071294 usd
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
24280 usd
CY2024Q2 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
69737923 usd
CY2024Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
65620003 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7378601 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5885238 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62359322 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
59734765 usd
CY2024Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3102081 usd
CY2023Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
225487 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1608718 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
628359 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5885238 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1498806 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3102081 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
225487 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1608718 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
628359 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
7378601 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1095934 usd
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1363656 usd
CY2024Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1363654 usd
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1655479 usd
CY2024Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1466840 usd
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
345785 usd
CY2024Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
270983 usd
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
41821 usd
CY2024Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
36483 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3406741 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3137960 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
744027 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
555503 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2662714 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2582457 usd
CY2024Q3 us-gaap Depreciation
Depreciation
188524 usd
CY2023Q3 us-gaap Depreciation
Depreciation
29118 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9000000 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
10000000 usd
CY2024Q3 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
75973 usd
CY2024Q3 us-gaap Other Income
OtherIncome
37593 usd
CY2023Q3 us-gaap Other Income
OtherIncome
0 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
42653 usd
CY2024Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
17280 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2245505 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2218166 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1875729 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2218166 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
988556 usd
CY2024Q3 ispr Contract Liabilities Recognized Related To Advanced Deposits
ContractLiabilitiesRecognizedRelatedToAdvancedDeposits
12927906 usd
CY2023Q3 ispr Contract Liabilities Recognized Related To Advanced Deposits
ContractLiabilitiesRecognizedRelatedToAdvancedDeposits
7003322 usd
CY2024Q3 ispr Revenue Recognized In Current Period
RevenueRecognizedInCurrentPeriod
12900567 usd
CY2023Q3 ispr Revenue Recognized In Current Period
RevenueRecognizedInCurrentPeriod
6701817 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2245505 usd
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1290061 usd
CY2024Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3295952 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3579140 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1240726 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1207832 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1869951 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2194094 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3110677 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
3401926 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1423190 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1269708 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
684329 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3377227 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
266550 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3110677 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
382559 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
278441 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y4M24D
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2024Q3 ispr Joint Venture Investment Payable Current
JointVentureInvestmentPayableCurrent
9000000 usd
CY2024Q2 ispr Joint Venture Investment Payable Current
JointVentureInvestmentPayableCurrent
9000000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
820705 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
575115 usd
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
71835 usd
CY2024Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
432863 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1179380 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1012353 usd
CY2024Q3 ispr Reserve For Product Returns Current
ReserveForProductReturnsCurrent
1066362 usd
CY2024Q2 ispr Reserve For Product Returns Current
ReserveForProductReturnsCurrent
717058 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
950 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
950 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
12139232 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
11738339 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5138263 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-845542 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0889 pure
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.5867 pure
CY2024Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
20405 shares
CY2024Q3 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
20000 shares
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
200000 shares
CY2024Q3 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
20000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3255000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.1
CY2024Q2 ispr Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Fair Value Per Option Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageFairValuePerOptionOutstanding
5.13
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y1M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
245000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.65
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.66
CY2024Q3 ispr Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Life In Months Grantedin Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeInMonthsGrantedinShares
P9Y9M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
335000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.84
CY2024Q3 ispr Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Fair Value Per Option Forfeiture
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageFairValuePerOptionForfeiture
5.59
CY2024Q3 ispr Sharebased Compensation Arrangement By Sharebased Payment Award Options Weighted Average Remaining Contractual Life In Months Forfeiturein Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsWeightedAverageRemainingContractualLifeInMonthsForfeitureinShares
P9Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3165000 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.91
CY2024Q3 ispr Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Fair Value Per Option Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageFairValuePerOptionOutstanding
5.04
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M24D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
627500 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.41
CY2024Q3 ispr Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Fair Value Per Option Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageFairValuePerOptionExercisable
5.07
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
567601 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
505979 usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M18D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y9M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.60 pure
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50 pure
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.04197 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
320876 usd
CY2023Q3 us-gaap Restricted Stock Expense
RestrictedStockExpense
461580 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2007588 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
967560 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14970232 usd
CY2024Q3 ispr Weighted Average Period
WeightedAveragePeriod
P2Y10M24D
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-5595016 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1341587 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56601320 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56601320 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54246212 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54246212 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3800238 shares
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3911817 shares
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2024Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2024Q3 ispr Leased Assets Obtained In Exchange For Operating Lease Liabilities
LeasedAssetsObtainedInExchangeForOperatingLeaseLiabilities
usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q3 ispr Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Fair Value Per Option Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageFairValuePerOptionExercised
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q3 ispr Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Fair Value Per Option Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageFairValuePerOptionExpired
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
shares
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001948455

Files In Submission

Name View Source Status
0001213900-24-096805-index-headers.html Edgar Link pending
0001213900-24-096805-index.html Edgar Link pending
0001213900-24-096805.txt Edgar Link pending
0001213900-24-096805-xbrl.zip Edgar Link pending
ea0219484-10q_ispire.htm Edgar Link pending
ea021948401ex31-1_ispire.htm Edgar Link pending
ea021948401ex31-2_ispire.htm Edgar Link pending
ea021948401ex32-1_ispire.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ispr-20240930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ispr-20240930_cal.xml Edgar Link unprocessable
ispr-20240930_lab.xml Edgar Link unprocessable
ispr-20240930_pre.xml Edgar Link unprocessable
ea0219484-10q_ispire_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ispr-20240930_def.xml Edgar Link unprocessable